Abstract: Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
Type:
Grant
Filed:
December 17, 2018
Date of Patent:
July 20, 2021
Assignee:
Anji Pharma (US) LLC
Inventors:
Alain D. Baron, Mark S. Fineman, Nigel R. A. Beeley
Abstract: Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
Type:
Grant
Filed:
July 17, 2018
Date of Patent:
June 2, 2020
Assignee:
Anji Pharma (US) LLC
Inventors:
Alain D. Baron, Mark S. Fineman, Nigel R. Beeley
Abstract: Provided herein are methods for treating conditions associated with a chemosensory receptor, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a chemosensory receptor ligand, such as a bitter receptor ligand. Also provided herein are chemosensory receptor ligand compositions, including bitter receptor ligand compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
Type:
Grant
Filed:
May 4, 2018
Date of Patent:
April 7, 2020
Assignee:
Anji Pharma (US) LLC
Inventors:
Alain D. Baron, Nigel R. A. Beeley, Mark S. Fineman
Abstract: Methods for improving the gastrointestinal tolerability of biguanide compounds and for treating metabolic disorders and/or inducing weight loss in patients in need thereof, particularly in individuals having a contraindication for treatment with biguanide compounds, are provided comprising administering delayed release formulations of such biguanide compounds, including metformin, targeted to the small intestine.
Type:
Grant
Filed:
September 21, 2017
Date of Patent:
March 31, 2020
Assignee:
Anji Pharma (US) LLC
Inventors:
Alain D. Baron, Mark S. Fineman, Nigel R. A. Beeley